Tumores Gastrintestinais

Metanálise (maioria de estudos observacionais) | Em pacientes submetidos a pancreatoduodenectomia, a descompressão nasogástrica de rotina está associada com taxas aumentadas de esvaziamento gástrico lento, complicações maiores e maior duração de internação, comparado com nenhuma descompressão.

10 Jan, 2022 | 12:00h

Impact of routine nasogastric decompression versus no nasogastric decompression after pancreaticoduodenectomy on perioperative outcomes: meta-analysis – BJS Open

Estudo relacionado: Nasogastric Decompression vs No Decompression After Pancreaticoduodenectomy: The Randomized Clinical IPOD Trial – JAMA Surgery

Comentário no Twitter

Nasogastric decompression after pancreaticoduodenectomy 🐘 what is your practice?!

👎 Routine NG tube associated with ⬆️ rates of DGE, major complications and longer length of stay

✅ @ErasSociety policies should be standard

New meta analys on @BjsOpen https://t.co/OStyWOfrPV pic.twitter.com/tuwjPYFWia

— Giovanni Marchegiani (@Gio_Marchegiani) January 3, 2022

Revisão | Imunoterapia para carcinoma hepatocelular.

14 Dez, 2021 | 16:05h

Immunotherapies for hepatocellular carcinoma – Nature Reviews Clinical Oncology (gratuito por tempo limitado – se o acesso a este link for pago, tente este)

Estudo de base populacional sobre câncer colorretal: incidência, mortalidade, características do tumor e tratamento antes e depois da introdução do programa de rastreamento baseado em testes imunoquímicos fecais na Holanda.

13 Dez, 2021 | 11:26h

Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study – The Lancet Gastroenterology & Hepatology (link para o resumo – $ para o texto completo)

Comentário no Twitter

New research – Breekveldt et al – #Colorectalcancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the FIT-based #screening programme in the #Netherlands: a population-based studyhttps://t.co/nW9SVAhRxE #GITwitter #crcsm pic.twitter.com/GGRF9Az0tg

— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) November 23, 2021

M-A | Eficácia e segurança associadas a inibidores do checkpoint imunológico no carcinoma hepatocelular irressecável.

8 Dez, 2021 | 12:58h

Efficacy and Safety Associated With Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma: A Meta-analysis – JAMA Network Open

Comentário no Twitter

This meta-analysis of RCTs shows immune checkpoint inhibitors are associated with demonstrated the superior efficacy and safety of versus standard systemic therapies in patients with unresectable hepatocellular carcinoma. https://t.co/fJdFng69qH

— JAMA Network Open (@JAMANetworkOpen) December 6, 2021